DAI-ICHI KARKARIA LTD. - Updates
| < Back | |
| 20 Sep 2013 | |
| Dai-Ichi Karkaria Ltd has informed BSE that pursuant to the Call Option under the Joint Venture and shareholders Agreement among GVK Biosciences P.Ltd. (GVK Bio), Dai-lchi Karkaria Limited (The Company) and Inogent Laboratories Pvt. Ltd. (Inogent), dated October 14, 2005, GVK BIO and its Parent Company - GVK Davix Technologies P. Ltd. have acquired 16,12,500 equity shares (i.e. 10% of voting powers) of Inogent from the Company on September 06, 2013 at a<br/>consideration aggregating to Rs. 8,49,64,018/- (Rupees Eight Crore Forty Nine Lacs Sixty Four Thousand and Eighteen Only).<br/><br/>Accordingly shareholding of the Company in Inogent after the acquisition is 9,87,500 equity shares (ie 6.12% of voting powers). | |
| View all announcements for DAI-ICHI KARKARIA LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback